News
4d
Interesting Engineering on MSNNew wearable tech detects diabetes risk early, eliminates need for needle pricksContinuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
Oura has announced a new glucose integration with Dexcom's Stelo and the permanent launch of its AI-powered food tracker, ...
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...
Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...
The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...
Is there such a thing as pre-prediabetes? My doctor says it’s happening to me, and he wants me to use one of those blood ...
12d
MedPage Today on MSNOzempic Blindness Lawsuit; CGM Integrates With Epic; Microdosing GLP-1 MedsIn a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...
(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.
Trends indicate increasing adoption among adults aged 20+, with significant expansion in the male CGM market. Key players include Dexcom, Inc., Abbott Laboratories, and Medtronic. The report offers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results